Literature DB >> 33633893

Atypical Presentation of Pulmonary Embolism Several Months After COVID-19 Infection.

Ayesha Jamil1, Vinayasree Shyam1, Karun Neupane2.   

Abstract

A 47-year-old female with a past medical history of morbid obesity and hypertension presented with acute onset dizziness that started while she was at work one evening. She did not have chest pain or dyspnea. She had vital signs within an acceptable range, oxygen saturation of 98%-99%, and was not in acute distress. Examination including the Dix-Hallpike maneuver was unremarkable. Computed tomography angiography (CTA) of the head and neck disclosed bilateral pulmonary embolism without any evidence of cerebral ischemia. CTA chest confirmed the diagnosis of bilateral pulmonary emboli. Importantly, besides the obesity, the patient did not have any other risk factors of pulmonary embolism including recent immobilization, surgery, hormonal therapy or contraceptive use, and personal or family history of thromboembolic disorders. However, she was diagnosed with COVID-19 infection six months back with symptoms not requiring hospitalization. Following further workup for her dizziness and neurology evaluation, in the absence of any other plausible etiology, her presenting symptom was attributed to the atypical presentation of pulmonary embolism. She was treated with heparin in the hospital and discharged on apixaban. Her symptoms had resolved at the time of discharge.
Copyright © 2021, Jamil et al.

Entities:  

Keywords:  atypical; covid 19; dizziness; pulmonary embolism (pe); sars-cov-2

Year:  2021        PMID: 33633893      PMCID: PMC7899286          DOI: 10.7759/cureus.12863

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

1.  Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.

Authors:  Seda Bilaloglu; Yin Aphinyanaphongs; Simon Jones; Eduardo Iturrate; Judith Hochman; Jeffrey S Berger
Journal:  JAMA       Date:  2020-08-25       Impact factor: 56.272

2.  The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.

Authors:  Marco Ranucci; Andrea Ballotta; Umberto Di Dedda; Ekaterina Bayshnikova; Marco Dei Poli; Marco Resta; Mara Falco; Giovanni Albano; Lorenzo Menicanti
Journal:  J Thromb Haemost       Date:  2020-05-06       Impact factor: 5.824

3.  A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infection.

Authors:  Mats Beckman; Sven Nyrén; Anna Kistner
Journal:  Thromb J       Date:  2020-08-28

4.  Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease.

Authors:  P D Stein; M L Terrin; C A Hales; H I Palevsky; H A Saltzman; B T Thompson; J G Weg
Journal:  Chest       Date:  1991-09       Impact factor: 9.410

5.  Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.

Authors:  Ian Léonard-Lorant; Xavier Delabranche; François Séverac; Julie Helms; Coralie Pauzet; Olivier Collange; Francis Schneider; Aissam Labani; Pascal Bilbault; Sébastien Molière; Pierre Leyendecker; Catherine Roy; Mickaël Ohana
Journal:  Radiology       Date:  2020-04-23       Impact factor: 11.105

Review 6.  COVID-19 is, in the end, an endothelial disease.

Authors:  Peter Libby; Thomas Lüscher
Journal:  Eur Heart J       Date:  2020-09-01       Impact factor: 29.983

Review 7.  Current Overview on Hypercoagulability in COVID-19.

Authors:  Namrata Singhania; Saurabh Bansal; Divya P Nimmatoori; Abutaleb A Ejaz; Peter A McCullough; Girish Singhania
Journal:  Am J Cardiovasc Drugs       Date:  2020-10       Impact factor: 3.571

Review 8.  Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review.

Authors:  Yasser Sakr; Manuela Giovini; Marc Leone; Giacinto Pizzilli; Andreas Kortgen; Michael Bauer; Tommaso Tonetti; Gary Duclos; Laurent Zieleskiewicz; Samuel Buschbeck; V Marco Ranieri; Elio Antonucci
Journal:  Ann Intensive Care       Date:  2020-09-16       Impact factor: 6.925

9.  Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.

Authors:  Elizabeth A Middleton; Xue-Yan He; Frederik Denorme; Robert A Campbell; David Ng; Steven P Salvatore; Maria Mostyka; Amelia Baxter-Stoltzfus; Alain C Borczuk; Massimo Loda; Mark J Cody; Bhanu Kanth Manne; Irina Portier; Estelle S Harris; Aaron C Petrey; Ellen J Beswick; Aleah F Caulin; Anthony Iovino; Lisa M Abegglen; Andrew S Weyrich; Matthew T Rondina; Mikala Egeblad; Joshua D Schiffman; Christian Con Yost
Journal:  Blood       Date:  2020-09-03       Impact factor: 25.476

  9 in total
  2 in total

1.  Thrombotic and Hemorrhagic Incidences in Patients After Discharge from COVID-19 Infection: A Systematic Review and Meta-Analysis.

Authors:  Tarinee Rungjirajittranon; Weerapat Owattanapanich; Nattawut Leelakanok; Natthaporn Sasijareonrat; Bundarika Suwanawiboon; Yingyong Chinthammitr; Theera Ruchutrakool
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 2.  Pulmonary Embolism in Post-CoviD-19 Patients, a Literature Review: Red Flag for Increased Awareness?

Authors:  Angeliki Mouzarou; Maria Ioannou; Elena Leonidou; Ioanna Chaziri
Journal:  SN Compr Clin Med       Date:  2022-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.